Histogenics (HSGX) Tops Q2 EPS by 5c
Tweet
Share
E-mailHistogenics (NASDAQ: HSGX) reported Q2 EPS of ($0.25), $0.05 better than the analyst estimate of ($0.30).
For earnings history and earnings-related data on Histogenics (HSGX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Trump said he was unaware of his earnings from crypto
- Concentrix Corporation (CNXC) Misses Q2 EPS by 1c; Guides lower than expectations
- FactSet (FDS) Tops Q3 EPS by 8c ; Offers Guidance
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
